Given the crucial role of RAC1 in survival and RAS-mediated transformation, and of RAC1 and RAC1b in modulating the TGF-β pathway, therapeutic targeting of TGF-β signaling in cancer cells with inhibitors of RAC1 and/or RAC1b provides an exciting perspective. Here, RAC1 is linked to cancer.